Lupin gets USFDA tentative approval for inhalation solutions
Lupin gets USFDA tentative approval for inhalation solutions

Lupin gets USFDA tentative approval for inhalation solutions

Apurva Joshi Article rating: 5.0

Lupin Limited has received a tentative approval for its Arformoterol Tartrate inhalation solution 15 mcg (base)/2 ml, unit-dose vials, from United States Food & Drug Administration (USFDA) to market generic version of Brovana inhalation solution, 15 mcg/2 ml of Sunovion Pharmaceuticals Inc.

What is sequencing risk all about?
What is sequencing risk all about?

What is sequencing risk all about?

DSIJ Intelligence Article rating: 4.3

There are various kinds of risk that we need to carry while investing. Sequencing risk is one such risk that specifically affects the retirement. So, what is sequencing risk? Let’s find out.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

DSIJ Intelligence Article rating: 4.0

The market opened in the green on April 29, 2020. The previous trading session witnessed the Sensex going up by 1.2 percent to end at 32,114 and the Nifty was up 1.1 percent to close at 9,380.

Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit
Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit

Hester Biosciences Ltd collaborates with IIT-G; hits upper circuit

DSIJ Intelligence Article rating: 4.1

Gujarat-based pharma company, Hester Biosciences Limited announced on Wednesday that it is joining hands with Indian Institute of Technology, Guwahati to work on the vaccine development against COVID-19. The agreement between the two parties was signed on April 15, 2020.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 3.4

The market opened in the green on April 29, 2020. The previous trading session witnessed the Sensex going up by 1.2 percent to end at 32,114 and the Nifty was up 1.1 percent to close at 9,380.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 3.7

The market opened in the green on April 29, 2020, overall volumes in futures & options currently stand at 1.71 crore contracts with a turnover of Rs. 9,04,461.82 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.8

The market opened in the green on April 29, 2020, overall volumes in futures & options currently stand at 1.71 crore contracts with a turnover of Rs. 9,04,461.82 crore.

IOL Chemicals shine on getting recognition from GOI
IOL Chemicals shine on getting recognition from GOI

IOL Chemicals shine on getting recognition from GOI

Avalokita Pandey Article rating: 3.5

The stock of organic chemicals manufacturer & supplier, IOL Chemicals & Pharmaceuticals Ltd, witnessed a jump today on being recognised as ‘three star export house’ by Ministry of Commerce & Industry, Government of India. 

Glenmark Pharma gets USFDA nod for Qtern generic
Glenmark Pharma gets USFDA nod for Qtern generic

Glenmark Pharma gets USFDA nod for Qtern generic

DSIJ Intelligence Article rating: 4.3

Glenmark Pharmaceuticals announced on Wednesday that it had been granted tentative approval by United States Food & Drug Administration (USFDA) for Dapagliflozin and Saxagliptin tablets, 10 mg/5 mg, the generic version of Qtern 1 tablets, 10 mg/5 mg of AstraZeneca AB.

RSS
First28272828282928302832283428352836Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR